Ioannis Xanthakis

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The impact of extraction vs. non-extraction orthodontic treatment on the angulation of third molars on panoramic radiographs: a systematic review and meta-analysis.

The impact of extraction vs. non-extraction orthodontic treatment on the angulation of third molars on panoramic radiographs: a systematic review and meta-analysis.

Journal: Progress in orthodontics

Published: May 07, 2025

Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece.

Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece.

Journal: Anticancer research

Published: February 19, 2025

Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel.

Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel.

Journal: Oncology letters

Published: September 13, 2022

Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.

Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.

Journal: Future oncology (London, England)

Published: August 05, 2022

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.

Journal: BMC cancer

Published: September 03, 2018

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.

Journal: Journal of translational medicine

Published: October 20, 2015

Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.

Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.

Journal: Anticancer research

Published: September 10, 2014

Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.

Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.

Journal: Anticancer research

Published: April 30, 2014

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

Journal: BMC cancer

Published: October 11, 2013

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.

Journal: BMC cancer

Published: July 02, 2013

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.

Journal: BMC cancer

Published: February 26, 2013

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.

Journal: BMC cancer

Published: November 21, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026